Chinese herbal add-on after breast surgery
Part of Cancer, Skin clinical trials.
This trial looks at whether a Chinese herbal complementary treatment used alongside standard radiation after breast cancer surgery can improve health outcomes. It is for women newly diagnosed with certain stages of breast cancer who are planning chest-wall radiation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman, age 18 or older
- You have been newly diagnosed with breast cancer
- You have had a mastectomy (breast removal), with or without reconstruction
- Your cancer is stage II to IIIb (not stage T4, and not spread to distant organs)
- You plan to get radiation to the chest wall (possibly nearby lymph nodes) soon after surgery
- You must be able to consent in English or Spanish and be willing to sign the study consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a Chinese herbal medicine (Shenbailing granules) can help improve energy and blood health in women recovering from breast cancer surgery.
This trial tests adding radiation therapy to chemotherapy before surgery for people with locally advanced breast cancer that did not shrink enough with chemo alone. It may help improve outcomes for those with luminal (HER2-negative) or triple-negative types.
This Phase 4 study tests an additional (adjuvant) treatment for breast cancer after surgery and standard follow-up care. It may help lower the chance the cancer comes back, but you must match specific tumor and body-chemistry requirements to join.
This trial is testing a new treatment approach for patients with a certain type of breast cancer (HR+/HER2-). It combines radiation therapy with chemotherapy and an immunotherapy drug before the patient's main surgery, to see if it can shrink or eliminate the tumor more effectively.
This trial tests combining two treatments—an immunotherapy drug (Toripalimab) and radiation—before surgery for a certain type of breast cancer (HR+, HER2-negative) that has spread to lymph nodes. The goal is to see if this combination helps shrink the tumor more than standard therapy alone.
This trial tests whether adding personalized Traditional Chinese Medicine to standard chemotherapy helps people with stage III colorectal cancer recover better after surgery. It's for patients who need chemotherapy and are open to trying TCM.
Hear when a new Skin Toxicity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.